Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

Publication | Open Access

DOI Full Paper Access

229

Citations

References

2010

Year

Lisa Licitra, Fernando Rivera, Éva Remenár, Ricardo Hitt, J. Erfán, Sylvie Rottey, Andrzej Kawecki, D. Zabolotnyy, Marco Benasso, Stephan Störkel,

Annals of Oncology

MedicinePathologyExtreme StudyFirst-line TreatmentHead And Neck CancerCancer TreatmentCancer GeneticsNeck OncologyOncologyRadiation OncologyPredictive Biomarker